Einat Brill Almon
2021
In 2021, Einat Brill Almon earned a total compensation of $627.8K as Senior Vice President, Chief Development Officer at Protalix BioTherapeutics, a 29% decrease compared to previous year.
Compensation breakdown
| Option Awards | $196,784 |
|---|---|
| Salary | $339,937 |
| Other | $91,044 |
| Total | $627,765 |
Almon received $339.9K in salary, accounting for 54% of the total pay in 2021.
Almon also received $196.8K in option awards and $91K in other compensation.
Rankings
In 2021, Einat Brill Almon's compensation ranked 10,194th out of 12,405 executives tracked by ExecPay. In other words, Almon earned more than 17.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,194 out of 12,405 | 18th |
Division Manufacturing | 4,505 out of 5,494 | 18th |
Major group Chemicals And Allied Products | 2,012 out of 2,369 | 15th |
Industry group Drugs | 1,783 out of 2,090 | 15th |
Industry Biological Products, Except Diagnostic Substances | 391 out of 452 | 14th |
Source: SEC filing on April 29, 2022.
Almon's colleagues
We found three more compensation records of executives who worked with Einat Brill Almon at Protalix BioTherapeutics in 2021.